Polymerizable Materials for Diffractive Optical Elements Recording

The technologies based on holographic and photonic techniques related to the optical storage and optical processing of information are rapidly evolving. One of the key points of this evolution are the new recording materials able to perform under the most specific situations and applications. In this sense, the importance of the photopolymers is growing spectacularly. This is mainly due to their versatility in terms of composition and design together with other interesting properties such as self-processing capabilities. In this chapter, we introduce the diffractive optical elements (DOE) generation in these materials and some of the most important parameters involved in this process. The deep knowledge of the material is essential to model its behavior during and after the recording process and we present different techniques to characterize the recording materials. We also present a 3D theoretical diffusion model able to reproduce and predict the experimental behavior of the recording process of any kind of DOE onto the photopolymers. The theoretical results will be supported by experimental analysis using a hybrid optical-digital setup, which includes a liquid crystal on silicon display. Besides this analysis, we study a method to improve the conservation and characteristics of these materials, an index-matching system

Holographic Data Storage Using Parallel-Aligned Liquid Crystal on Silicon Displays

The parallel-aligned liquid crystal on silicon (PA-LCoS) microdisplay has become a widely used device for the photonics community. It is a very versatile tool that can perform several tasks which transforms it into a key element in many different photonics applications. Since our group is interested in holography, in this chapter, we want to use these displays as the data entry point for a holographic data storage system (HDSS). Due to the novelty of this kind of device, we have done an intense work characterizing it. These efforts are reflected in this chapter where the reader will find two different characterization methods that will enable to predict the performance of the device in a specific application. Additionally, we present how a phase-only device can be used as a data pager using different modulation schemes and combined with a photopolymer as the holographic recording material

Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

BACKGROUND: Faecal immunochemical test (FIT) has been recommended to assess symptomatic patients for colorectal cancer (CRC) detection. Nevertheless, some conditions could theoretically favour blood originating in proximal areas of the gastrointestinal tract passing through the colon unmetabolized. A positive FIT result could be related to other gastrointestinal cancers (GIC). AIM To assess the risk of GIC detection and related death in FIT-positive symptomatic patients (threshold 10 mu g Hb/g faeces) without CRC. METHODS: Post hoc cohort analysis performed within two prospective diagnostic test studies evaluating the diagnostic accuracy of different FIT analytical systems for CRC and significant colonic lesion detection. Ambulatory patients with gastrointestinal symptoms referred consecutively for colonoscopy from primary and secondary healthcare, underwent a quantitative FIT before undergoing a complete colonoscopy. Patients without CRC were divided into two groups (positive and negative FIT) using the threshold of 10 mu g Hb/g of faeces and data from follow-up were retrieved from electronic medical records of the public hospitals involved in the research. We determined the cumulative risk of GIC, CRC and upper GIC. Hazard rate (HR) was calculated adjusted by age, sex and presence of significant colonic lesion. RESULTS: We included 2709 patients without CRC and a complete baseline colonoscopy, 730 (26.9%) with FIT >= 10 mu gr Hb/gr. During a mean time of 45.5 +/- 20.0 mo, a GIC was detected in 57 (2.1%) patients: An upper GIC in 35 (1.3%) and a CRC in 14 (0.5%). Thirty-six patients (1.3%) died due to GIC: 22 (0.8%) due to an upper GIC and 9 (0.3%) due to CRC. FIT-positive subjects showed a higher CRC risk (HR 3.8, 95%CI: 1.2-11.9) with no differences in GIC (HR 1.5, 95%CI: 0.8-2.7) or upper GIC risk (HR 1.0, 95%CI: 0.5-2.2). Patients with a positive FIT had only an increased risk of CRC-related death (HR 10.8, 95%CI: 2.1-57.1) and GIC-related death (HR 2.2, 95%CI: 1.1-4.3), with no differences in upper GIC-related death (HR 1.4, 95%CI: 0.6-3.3). An upper GIC was detected in 22 (0.8%) patients during the first year. Two variables were independently associated: anaemia (OR 5.6, 95%CI: 2.2-13.9) and age >= 70 years (OR 2.7, 95%CI: 1.1-7.0). CONCLUSION Symptomatic patients without CRC have a moderate risk increase in upper GIC, regardless of the FIT result. Patients with a positive FIT have an increased risk of post-colonoscopy CRC

Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study

Simple Summary An increased risk of hematological malignancies, mainly lymphomas, has been described in patients with inflammatory bowel disease (IBD). Because there are scarce data about the management and evolution of lymphomas in patients with IBD, the aim of our study was to analyze these points in those patients with IBD and lymphoma diagnosis included in the prospectively maintained ENEIDA registry of GETECCU. We identified 52 patients (2.4 cases of lymphoma/1000 patients with IBD). We found that most IBD patients had been treated with thiopurines and/or anti-TNF agents before lymphoma diagnosis, and these patients were younger at diagnosis of lymphoma than those not treated with these drugs. Relapse and mortality of lymphoma were not related with these therapies. The five-year survival rate was 85% for non-Hodgkin lymphoma and 84% in patients with Hodgkin lymphoma. An increased risk of lymphoma has been described in patients with inflammatory bowel disease (IBD). The aims of our study were to determine the clinical presentation, the previous exposure to immunosuppressive and biologic therapies, and the evolution of lymphomas in patients with IBD. IBD patients with diagnosis of lymphoma from October 2006 to June 2021 were identified from the prospectively maintained ENEIDA registry of GETECCU. We identified 52 patients (2.4 cases of lymphoma/1000 patients with IBD; 95% CI 1.8-3.1). Thirty-five were men (67%), 52% had ulcerative colitis, 60% received thiopurines, and 38% an anti-TNF drug before lymphoma diagnosis. Age at lymphoma was lower in those patients treated with thiopurines (53 +/- 17 years old) and anti-TNF drugs (47 +/- 17) than in those patients not treated with these drugs (63 +/- 12; p < 0.05). Five cases had relapse of lymphoma (1.7 cases/100 patient-years). Nine patients (17%) died after 19 months (IQR 0-48 months). Relapse and mortality were not related with the type of IBD or lymphoma, nor with thiopurines or biologic therapies. In conclusion, most IBD patients had been treated with thiopurines and/or anti-TNF agents before lymphoma diagnosis, and these patients were younger at diagnosis of lymphoma than those not treated with these drugs. Relapse and mortality of lymphoma were not related with these therapies

Analysis of a vertically aligned liquid-crystal on silicon microdisplay for photonics applications

We present the characterization results for an analogically addressed vertically aligned liquid crystal on silicon microdisplay (VA-LCoS). We show that it covers more than 360º phase modulation range at 1550 nm, and that in the visible the range available enables the generation of multiorder DOEs. There are basically no studies dealing with the characterization of vertically aligned high resolution LCoS devices, since the ones typically found in the literature and commercially available correspond to the parallel aligned. We have also verified that the microdisplay used in this work is free from flicker, which is a very interesting feature for application where the phase stability is of the utmost importance. The results shown here represent a first step in the work underway oriented to the generation of programmable DOEs for telecommunication applications (C-band) and for the visible spectrum

Spanish Version of the Family Health Behavior Scale: Adaptation and Validation

Different studies around the world indicate that the percentages of overweight and obesity in childhood and adolescence are high. In this context, it would be useful to have a common, valid, and reliable instrument to assess health behaviors of families that allows comparisons of data from different countries. The objective is the adaptation of a Spanish version of the Family Health Behavior Scale (FHBS). The questionnaire originally developed by Moreno group was translated and adapted following the International Test Commission protocol. Its psychometric properties were evaluated through analysis of internal consistency, factor analysis and other evidences of validity. The Spanish version of the FHBS demonstrated adequate reliability coefficients, and its factor structure sufficiently replicated that obtained by the original measurement. The results suggested that the adapted version of the questionnaire was an adequate and valid measure for the evaluation of family health behaviors related to the prevention of overweight and obesity

Jornadas interhospitalarias: modelo de trabajo de las competencias laborales en el Grado de Medicina

La cercanía al mundo profesional es uno de los objetivos de los cursos superiores del Grado de Medicina. A través de la experiencia de compartir trabajos en el entorno profesional, los estudiantes adquieren diferentes competencias necesarias para su formación. El objetivo de esta experiencia ha sido capacitar a los estudiantes para defender sus trabajos en un entorno laboral compartiendo experiencias con profesionales y estudiantes de otros entornos universitarios y clínicos. Durante la asignatura Urgencias y Toxicología, que se imparte en el 6º curso del Grado de Medicina del Hospital Universitario de Getafe, los alumnos han realizado su aprendizaje sobre el estudio de casos de pacientes reales. A los alumnos se les propuso participar en la VIII Reunión Inter-Hospitalaria de Casos Clínicos de Urgencias para Residentes. También participaron en las jornadas médicos y estudiantes de otros hospitales. Las jornadas se desarrollaron en el mes de Diciembre del 2013. Durante su participación los alumnos expusieron la resolución del caso planteado y la solución del suyo ante médicos especialistas de varios hospitales y ante el comité organizador. Los estudiantes aprendieron a competir y a defender casos cerrados en un entorno profesional. La tutorización y mentorización de sus profesores fue muy valorada.SIN FINANCIACIÓNNo data 2014UE

In Vivo Application of Short-Lag Spatial Coherence and Harmonic Spatial Coherence Imaging in Fetal Ultrasound

BACKGROUND Faecal immunochemical test (FIT) has been recommended to assess symptomatic patients for colorectal cancer (CRC) detection. Nevertheless, some conditions could theoretically favour blood originating in proximal areas of the gastrointestinal tract passing through the colon unmetabolized. A positive FIT result could be related to other gastrointestinal cancers (GIC). AIM To assess the risk of GIC detection and related death in FIT-positive symptomatic patients (threshold 10 mu g Hb/g faeces) without CRC. METHODS Post hoc cohort analysis performed within two prospective diagnostic test studies evaluating the diagnostic accuracy of different FIT analytical systems for CRC and significant colonic lesion detection. Ambulatory patients with gastrointestinal symptoms referred consecutively for colonoscopy from primary and secondary healthcare, underwent a quantitative FIT before undergoing a complete colonoscopy. Patients without CRC were divided into two groups (positive and negative FIT) using the threshold of 10 mu g Hb/g of faeces and data from follow-up were retrieved from electronic medical records of the public hospitals involved in the research. We determined the cumulative risk of GIC, CRC and upper GIC. Hazard rate (HR) was calculated adjusted by age, sex and presence of significant colonic lesion. RESULTS We included 2709 patients without CRC and a complete baseline colonoscopy, 730 (26.9%) with FIT >= 10 mu gr Hb/gr. During a mean time of 45.5 +/- 20.0 mo, a GIC was detected in 57 (2.1%) patients: An upper GIC in 35 (1.3%) and a CRC in 14 (0.5%). Thirty-six patients (1.3%) died due to GIC: 22 (0.8%) due to an upper GIC and 9 (0.3%) due to CRC. FIT-positive subjects showed a higher CRC risk (HR 3.8, 95%CI: 1.2-11.9) with no differences in GIC (HR 1.5, 95%CI: 0.8-2.7) or upper GIC risk (HR 1.0, 95%CI: 0.5-2.2). Patients with a positive FIT had only an increased risk of CRC-related death (HR 10.8, 95%CI: 2.1-57.1) and GIC-related death (HR 2.2, 95%CI: 1.1-4.3), with no differences in upper GIC-related death (HR 1.4, 95%CI: 0.6-3.3). An upper GIC was detected in 22 (0.8%) patients during the first year. Two variables were independently associated: anaemia (OR 5.6, 95%CI: 2.2-13.9) and age >= 70 years (OR 2.7, 95%CI: 1.1-7.0). CONCLUSION Symptomatic patients without CRC have a moderate risk increase in upper GIC, regardless of the FIT result. Patients with a positive FIT have an increased risk of post-colonoscopy CRC.Supported by Instituto de Salud Carlos III through the project PI17/00837 (Co-funded by European Regional Development Fund/European Social Fund "A way to make Europe"/"Investing in your future")